Unverified50% confidenceOpinionExact time
The study has limitations: the calibration advantage of synthetic data is unstable, clinical plausibility still requires physician involvement to improve, and the external generalizability to private cohorts awaits further validation.
1
Sources
50%
Confidence
Long-term
Relevance
11/10/2026
First Seen
Sources
Related Entities
Related Claims
UnverifiedEfficacy and safety validation in the clinical stage is not shortened by algorithmic advances, because it involves complex physiological mechanisms, individual differences and long-term follow-up, with sparse and hard-to-simulate data.75% similarUnverifiedKey controversies in psychedelic research include small experimental sample sizes, insufficient long-term safety data, and uncertainty in efficacy due to individual differences74% similarUnverifiedThe weak cross-platform ranking correlation suggests that methodological robustness and generalizability of conclusions are different things, and further cross-data-source consistency validation is still needed before advancing toward clinical decision-making.74% similarUnverifiedA single diagnostic accuracy metric is insufficient to support a conclusion of "surpassing doctors"; regulatory approval is the key threshold for a product to reach the market.73% similar
Cite This Claim
Stable URI
https://kongchang.com/claim/1153551API
curl https://kongchang.com/api/v1/knowledge/claims/1153551MCP
get_claim(id=1153551)